![]() |
As part of its commitment to embracing digital transformation, Fangzhou hosted a series of summits on "Data and AI: Decoding Digital Engagement" in various cities across China, including Shanghai, Chengdu, and Beijing. At these events, the Company showcased its innovative solutions and successful experiences in Internet healthcare with industry partners, providing valuable insights on the effective implementation of digital healthcare solutions.
About Fangzhou Inc.
Fangzhou Inc. (06086.HK) is China's leading online chronic disease management platform. With 45.6 million registered users and 217,000 registered doctors on its platform (as of June 30, 2024), the Company provides tailored medical care and precision medicine for a growing population of chronic disease patients. For more details, visit https://investors.jianke.com.
About the "Analysys Star Annual Award List"
Analysys International is a leading technology and market analysis firm focused on providing intelligence and research on China's digital economy. For more than 10 years, the "Analysys Star Annual Award List" has showcased significant achievements in China's digital economy sector. This year's awards were focused on the theme of emerging trends in "Digital Intelligence Innovation". Enterprises and their products were assessed across multiple dimensions including business models, technical strengths, user scale and experience, operational efficiency, and competitive strengths, with each award recipient having a profound influence on their respective industries.
Media Contact
For further inquiries or interviews, please reach out to:
Xingwei Zhao Associate Director of Public Relations Email: [email protected]
Disclaimer: This press release contains forward-looking statements. Actual results may differ materially from those anticipated due to various factors. Readers are cautioned not to place undue reliance on these statements